SCHEMBL20021183

SCHEMBL20021183

Cc1cc2nc(/C(C=N)=C/N)ccc2c(-c2ccc(Cl)cc2)c1CC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.39
GRM2 Q14416 1/20 0.39
PTGDR2 Q9Y5Y4 7/20 0.35
LMNA P02545 1/20 0.35
DHODH Q02127 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C8 P10632 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2A6 P11509 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CA12 O43570 1/20 0.32
CA9 Q16790 1/20 0.32
AURKA O14965 1/20 0.32
AURKB Q96GD4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3321643 0.81 KDM4E (0.48) KDM4ESMN1; SMN2GRM2PTGDR2LMNA
SCHEMBL3297610 0.80 KDM4E (0.54) KDM4ESMN1; SMN2GRM2PTGDR2LMNA
SCHEMBL10284333 0.80 KDM4E (0.47) KDM4ESMN1; SMN2LMNACYP1A2CYP2C19
SCHEMBL3303954 0.79 KDM4E (0.53) KDM4ESMN1; SMN2PTGDR2LMNADHODH
SCHEMBL20021122 0.78 KDM4E (0.52) KDM4ESMN1; SMN2GRM2PTGDR2LMNA
SCHEMBL20020768 0.78 CNR1 (0.45) KDM4ESMN1; SMN2PTGDR2ALDH1A1
SCHEMBL3323941 0.77 KDM4E (0.51) KDM4ESMN1; SMN2PTGDR2LMNADHODH
SCHEMBL10284334 0.77 KDM4E (0.49) KDM4ESMN1; SMN2PTGDR2LMNADHODH
SCHEMBL20020760 0.77 KDM4E (0.48) KDM4ESMN1; SMN2PTGDR2LMNACYP1A2
SCHEMBL3324004 0.77 KDM4E (0.48) KDM4ESMN1; SMN2PTGDR2LMNADHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588455-B1 2-QUINOLINYL-ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS GILEAD SCIENCES INC (US) 2018-04-04 EP disclosed